Homology Medicines Inc
(LTS:0T6G)
$
135
0.000001 (0%)
Market Cap: 3.02 Mil
Enterprise Value: -78.32 Mil
PE Ratio: 0
PB Ratio: 0.04
GF Score: 32/100 Homology Medicines Inc (LTS:0T6G) Transcripts
- Homology Medicines Inc to Announce Encouraging First Dose Level Initial Data Call TranscriptJul 27, 2023
- Homology Medicines Inc Annual Shareholders Meeting TranscriptJun 14, 2023
- Homology Medicines Inc at Stifel Healthcare Conference TranscriptNov 15, 2022
- Homology Medicines Inc Annual Shareholders Meeting TranscriptJun 15, 2022
- Homology Medicines Inc ASGCT Symposium TranscriptMay 18, 2022
- Homology Medicines Inc at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Homology Medicines Inc to Discuss Transaction with Oxford Biomedica and Provide an Update on Clinical Programs and Product Pipeline TranscriptJan 28, 2022
- Homology Medicines Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 08, 2021
- Homology Medicines Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) TranscriptOct 13, 2021
- Homology Medicines Inc at Bank of America NAPA Healthcare Conference TranscriptJun 15, 2021
- Homology Medicines Inc Corporate and Pipeline Updates TranscriptMay 13, 2021
- Homology Medicines Inc At Cell Gene Meeting on the Mesa TranscriptJan 08, 2021
- Homology Medicines Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) TranscriptOct 12, 2020
- Homology Medicines Inc To Host Emerging Therapies and Clinical Trials Event TranscriptAug 25, 2020
- 1